Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Why Dendreon's begging bowl repels investors

This article was originally published in Scrip

Executive Summary

Dendreon's market capitalization hit a 10-year low on 12 August 2014. As if primed to expect bad news in August (Dendreon's stock price and valuation have fallen by more than 30% in each of the last four Augusts), the reaction from the market was almost instantaneous: Dendreon's share price dropped from $2.11 at the close on 11 August to $1.54 at the start of 12 August closing at $1.38, a 35% loss on the day wiping 33% or $115m of the company's increasingly meager valuation.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC026089

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel